Nucotrim Tablets Used For

Nucotrim Tablets Used For: A Detailed, Fact-Based Guide (South Africa)

Nucotrim Tablets are a prescription antibiotic medicine available in South Africa that contain a fixed-dose combination of sulfamethoxazole and trimethoprim, also known as co‑trimoxazole. They are mainly used to treat specific bacterial infections, and their use must always be guided by a healthcare professional.

Below is a concise, factual overview of what Nucotrim tablets are used for, based entirely on credible, verifiable sources.

What Are Nucotrim Tablets?

According to the South African electronic Medicines Compendium (eMC) for South Africa, Nucotrim Tablets are a branded co‑trimoxazole product containing:

Sulfamethoxazole 400 mg
Trimethoprim 80 mg

per tablet, in a fixed ratio combination of 5:1 sulfamethoxazole to trimethoprim. This is clearly specified in the South African package insert for Nucotrim Tablets hosted on the South African eM Guidance / medicine information service (see the Nucotrim Tablet professional information document).

The same official document notes that Nucotrim is a broad‑spectrum antibacterial combination acting by inhibiting sequential steps in bacterial folate synthesis, which leads to a synergistic bactericidal effect.

Main Indications: What Nucotrim Tablets Are Used For

The approved indications for Nucotrim Tablets in South Africa, as listed in the official professional information for co‑trimoxazole (Nucotrim) on the South African medicines database, include the treatment of the following infections caused by susceptible organisms:

Urinary Tract Infections (UTIs)
Nucotrim tablets are indicated for acute and chronic urinary tract infections due to susceptible bacteria, such as certain strains of Escherichia coli and other sensitive organisms. This is stated in the South African Nucotrim data sheet (co‑trimoxazole professional information).
Respiratory Tract Infections
The same official Nucotrim documentation notes it is used for acute and chronic bronchitis and chronic obstructive airways disease exacerbations caused by susceptible organisms, and for certain upper respiratory tract infections, when the causative bacteria are known or strongly suspected to be sensitive.
Gastrointestinal and Enteric Infections
According to the product information for co‑trimoxazole listed in South African medicine references, Nucotrim (co‑trimoxazole) is indicated for some gastrointestinal infections, including shigellosis and other infections due to susceptible strains of Shigella and certain other enteric bacteria (co‑trimoxazole indications summary).
Skin and Soft Tissue Infections
The South African professional information indicates that co‑trimoxazole is used in some skin and soft tissue infections where the causative organisms are susceptible, for example certain staphylococcal infections. This is again drawn directly from the Nucotrim/co‑trimoxazole product information on the South African medicines database.
Pneumocystis jirovecii Pneumonia (PJP / PCP)
Co‑trimoxazole is widely recognised in clinical guidelines as a first‑line treatment and prophylactic agent for Pneumocystis jirovecii pneumonia (PJP), particularly in immunocompromised patients (such as people living with HIV). South African HIV and PJP treatment guidelines reference co‑trimoxazole for this indication; for example, the Southern African HIV Clinicians Society guideline on preventing opportunistic infections lists co‑trimoxazole as standard prophylaxis for PJP and certain bacterial infections in HIV‑positive adults and children (Southern African HIV Clinicians Society guideline, see the section on cotrimoxazole prophylaxis).
Toxoplasmosis (as part of HIV‑related care, where appropriate)
The same HIV guidelines note that co‑trimoxazole prophylaxis in people with advanced HIV reduces the risk of toxoplasmosis along with other opportunistic infections (Southern African HIV Clinicians Society guideline – see the discussion of cotrimoxazole’s benefits).

In practice, South African prescribers typically use Nucotrim Tablets where a co‑trimoxazole product is indicated and the specific Nucotrim brand is available and appropriate.

How Nucotrim Tablets Work

The mechanism of action is described in the South African co‑trimoxazole (Nucotrim) professional information:

Trimethoprim blocks the bacterial enzyme dihydrofolate reductase.
Sulfamethoxazole inhibits dihydropteroate synthase.

By sequentially blocking two steps in bacterial folate synthesis, the combination exerts a synergistic bactericidal effect against susceptible organisms (co‑trimoxazole pharmacology in the Nucotrim tablet insert).

Dosage Forms and Typical Strength

From the South African Nucotrim tablet professional information:

Each Nucotrim tablet contains 400 mg sulfamethoxazole + 80 mg trimethoprim.
There is also a higher‑strength “double strength” co‑trimoxazole tablet (not always branded Nucotrim), but the Nucotrim brand in South Africa is commonly specified in the 400/80 mg strength (co‑trimoxazole tablet strength details).

Exact dosing, frequency, and duration vary by infection type, severity, kidney function, age, and other factors, and must be determined by a prescriber using up‑to‑date guidelines.

Important Safety Information and Warnings

The official co‑trimoxazole / Nucotrim documentation and South African clinical guidelines highlight several important safety considerations:

Allergy and Serious Skin Reactions
Sulfonamide‑containing medicines like sulfamethoxazole can cause serious hypersensitivity reactions, including Stevens‑Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The Nucotrim professional information warns that treatment must be stopped immediately at the first sign of rash or any serious reaction (co‑trimoxazole safety and adverse effects).
Blood Disorders
Co‑trimoxazole can in rare cases cause blood dyscrasias such as agranulocytosis, aplastic anaemia, thrombocytopenia, or leucopenia. The professional information advises periodic blood count monitoring in patients receiving prolonged or high‑dose therapy (Nucotrim adverse reactions and monitoring).
Renal Impairment
Since both components are excreted by the kidneys, dose adjustment is required in renal impairment, and the drug may be contraindicated or used with great caution in severe renal dysfunction. This is clearly highlighted in the dosing and precautions section of the Nucotrim insert.
Folate Deficiency and Certain Patient Groups
Fatalities have occurred, especially in the elderly or those with serious underlying disorders. Co‑trimoxazole can exacerbate folate deficiency, so care is needed in patients with pre‑existing folate deficiency or those on drugs that affect folate metabolism (professional information, warnings and precautions).
Pregnancy and Breastfeeding
South African and international references caution that co‑trimoxazole should be used in pregnancy only when clearly needed, particularly avoiding use close to term because of theoretical risks related to folate interference and neonatal jaundice. Breastfeeding considerations are also described in the professional information and broader co‑trimoxazole literature; prescribers are advised to weigh risks and benefits in each case.

Because of these potential risks, Nucotrim tablets should only be used under medical supervision, with attention to contraindications, drug interactions, and necessary monitoring. The official South African professional information is the primary source for these safety details (Nucotrim tablet insert).

Nucotrim Tablets and Antibiotic Stewardship

South African and global guidelines emphasise the importance of antibiotic stewardship to reduce antimicrobial resistance. A 2023 South African antimicrobial stewardship position statement (for example, the stewardship materials referenced by the National Department of Health – South Africa and academic stewardship programmes) stresses that agents like co‑trimoxazole should be:

Used only when clearly indicated
Selected based on culture and sensitivity where possible
Given for the shortest effective duration

This is aligned with the principles discussed in South African antimicrobial guidelines (e.g., the National Essential Medicines List Standard Treatment Guidelines, which incorporate co‑trimoxazole use in urinary, respiratory, and HIV‑related opportunistic infections; see the Adult Hospital Level STGs/EML, National Department of Health, South Africa: Adult Hospital Level STGs/EML PDF).

When to Seek Medical Advice

Given the potential for serious side effects and the need for correct diagnosis of bacterial infections, Nucotrim Tablets should never be used without a prescription.

You should consult a doctor or pharmacist:

If you think you have a urinary tract infection, bronchitis, or another infection and wonder whether Nucotrim tablets are appropriate.
If you are HIV‑positive and have questions about co‑trimoxazole prophylaxis for opportunistic infections such as PJP or toxoplasmosis (see the Southern African HIV Clinicians Society ART guidelines for the rationale for prophylaxis and when it is indicated:
Southern African HIV Clinicians Society Adult ART Guidelines).
If you are taking Nucotrim and develop rash, fever, mouth ulcers, unexplained bruising or bleeding, difficulty breathing, or jaundice, as these may be signs of serious adverse reactions and require urgent medical evaluation (Nucotrim warnings and adverse effect profile).

Summary: Nucotrim Tablets Used For

Based on current South African professional information and clinical guidance:

Active ingredients: sulfamethoxazole 400 mg + trimethoprim 80 mg per tablet (Nucotrim/co‑trimoxazole tablet information).
Pharmacological class: fixed‑dose combination antibacterial (co‑trimoxazole) that inhibits folate synthesis in bacteria.
Nucotrim tablets are used for:
- Certain urinary tract infections
- Specific respiratory tract infections (e.g., acute/chronic bronchitis caused by susceptible organisms)
- Particular gastrointestinal infections (e.g., shigellosis due to susceptible strains)
- Some skin and soft tissue infections caused by sensitive bacteria
- Treatment and prophylaxis of Pneumocystis jirovecii pneumonia (PJP) in immunocompromised patients, particularly in HIV care (Southern African HIV Clinicians Society guidelines)
- Prevention of certain opportunistic infections, including toxoplasmosis, in people with advanced HIV when indicated.

Nucotrim Tablets are a prescription‑only medicine. Their use must always be guided by a qualified healthcare professional following up‑to‑date South African guidelines and the official Nucotrim professional information available through the national medicines database (Nucotrim Tablets – co‑trimoxazole product information).